Caris Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CAI and other ETFs, options, and stocks.About CAI
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects.
CEODavid Dean Halbert
CEODavid Dean Halbert
Employees—
Employees—
HeadquartersIrving, Texas
HeadquartersIrving, Texas
Founded2008
Founded2008
Employees—
Employees—
CAI Key Statistics
Market cap8.00B
Market cap8.00B
Price-Earnings ratio-11.67
Price-Earnings ratio-11.67
Dividend yield—
Dividend yield—
Average volume2.96M
Average volume2.96M
High today$28.40
High today$28.40
Low today$26.90
Low today$26.90
Open price$27.53
Open price$27.53
Volume2.62M
Volume2.62M
52 Week high$42.50
52 Week high$42.50
52 Week low$21.00
52 Week low$21.00
Stock Snapshot
With a market cap of 8B, Caris Life Sciences(CAI) trades at $28.00. The stock has a price-to-earnings ratio of -11.67.
During the trading session on 2025-12-04, Caris Life Sciences(CAI) shares reached a daily high of $28.40 and a low of $26.90. At a current price of $28.00, the stock is +4.1% higher than the low and still -1.4% under the high.
Trading volume for Caris Life Sciences(CAI) stock has reached 2.62M, versus its average volume of 2.96M.
Over the past 52 weeks, Caris Life Sciences(CAI) stock has traded between a high of $42.50 and a low of $21.00.
Over the past 52 weeks, Caris Life Sciences(CAI) stock has traded between a high of $42.50 and a low of $21.00.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own CAI. This list is generated using Robinhood data, and it’s not a recommendation.